Explore the latest news and developments in the San Diego, CA pharmaceutical industry on our dedicated category page. Stay informed about groundbreaking research, innovations in drug development, and key partnerships among biotech companies and pharmaceutical firms. Discover stories highlighting local startups that are making waves in the life sciences sector, as well as updates on clinical trials and regulatory approvals. Our curated content focuses on advancements in pharmaceuticals, biotechnology trends, and the impact of local research institutions on the global healthcare landscape.
In addition to news articles, this category page offers insights into events, conferences, and forums taking place in San Diego that focus on the pharmaceutical sector. Learn about prominent figures and thought leaders in the industry who are shaping the future of medicine and healthcare. Whether you are a healthcare professional, researcher, or simply interested in the pharmaceutical innovations emerging from San Diego, this page serves as your go-to resource for comprehensive coverage and analysis. Keep up with the evolving landscape of pharmaceuticals in one of the country’s leading biotech hubs.
San Diego, February 6, 2026 Aro Biotherapeutics has announced promising preliminary results from a Phase 1b clinical trial of ABX1100, a muscle-targeted siRNA therapy for late-onset
San Diego, February 6, 2026 American International Group, Inc. (AIG) is facing scrutiny due to allegations of potential fiduciary breaches by its directors and officers. Scott+Scott
San Diego, February 6, 2026 SelectQuote, Inc. has reported significant financial growth with total revenue of $537.1 million for the quarter ending December 31, 2025, despite
San Diego, CA, February 5, 2026 Rite Aid Corporation has announced the closure of all its remaining stores in the United States following a second Chapter
San Diego, January 30, 2026 Eli Lilly has partnered with Repertoire Immune Medicines in a strategic alliance valued at up to $1.93 billion to develop innovative
San Diego, January 29, 2026 Halozyme Therapeutics, based in San Diego, has significantly increased its revenue forecasts for 2025 and 2026, showcasing strong projected growth driven
San Diego, January 27, 2026 Vistagen Therapeutics is facing a class action lawsuit filed on behalf of investors following the disappointing results of its Phase 3
San Diego, January 23, 2026 Biocom has unveiled an esteemed keynote panel for its upcoming Global Partnering & Investor Conference, featuring leaders from Amgen, AbbVie, and
San Diego, California, January 21, 2026 Crown Bioscience has announced that its San Diego laboratory has received accreditation from the College of American Pathologists (CAP). This
San Francisco, California, January 14, 2026 Sonoma Biotherapeutics has announced a significant workforce reduction in a bid to extend its financial runway and refocus on strategic
